On:

TOKYO, Mar 31, 2021 – (JCN Newswire via SEAPRWire.com) – KYORIN Pharmaceutical Co., Ltd., a subsidiary of KYORIN Holdings, Inc., and Eisai Co., Ltd. have entered into a license agreement for development and distribution of vibegron, a therapeutic agent for overactive bladder, in four ASEContinue Reading

On:

TOKYO, Mar 31, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and MSD K.K. a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., (known as MSD outside the United States and Canada) announced today that Eisai has submitted an application in Japan for the additional iContinue Reading

On:

HONG KONG, Mar 31, 2021 – (ACN Newswire via SEAPRWire.com) – The board (the “Board”) of directors (the “Directors”) of Genertec Universal Medical Group Company Limited (the “Company” or “Universal Medical”) is pleased to announce the annualContinue Reading

On:

HONG KONG, Mar 31, 2021 – (ACN Newswire via SEAPRWire.com) – China Development Bank Financial Leasing Co., Ltd. (stock code: 1606.HK; “CDB Leasing” or “the Company”, together with its subsidiaries as “the Group”) announces its audited consolidated resuContinue Reading